NEOADJUVANT HIGH-DOSE METHOTREXATE, CISPLATIN, AND DOXORUBICIN FOR THE MANAGEMENT OF PATIENTS WITH NONMETASTIC OSTEOSARCOMA

  • 1 December 1986
    • journal article
    • research article
    • Vol. 70  (12) , 1431-1432
Abstract
No abstract available